Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Labiana Health's Cash Flow for Lease Financing for the
six
months ended in Dec. 2025 was €0.00 Mil.
Labiana Health's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.
Compared with last quarter (€0.00 Mil in Jun. 2025 ), Labiana Health's Cash Flow for Lease Financing remained the same in Dec. 2025 (€0.00 Mil).
Labiana Health Cash Flow for Lease Financing Related Terms
Labiana Health Cash Flow for Lease Financing Historical Data
* Premium members only.
The historical data trend for Labiana Health's Cash Flow for Lease Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labiana Health Cash Flow for Lease Financing Chart
Labiana Health Cash Flow for Lease Financing Calculation
Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.
Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow for Lease Financing of €0.00 Mil mean?
Labiana Health (XMAD:LAB) has a Cash Flow for Lease Financing of €0.00 Mil as of Dec. 2025. Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing. View historical data on Labiana Health and its competitors.
Is Labiana Health's Cash Flow for Lease Financing too high?
Labiana Health's current Cash Flow for Lease Financing is €0.00 Mil. Overall, Labiana Health has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Labiana Health's Cash Flow for Lease Financing compare to ZTS and UTHR?
Labiana Health's Cash Flow for Lease Financing of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Lease Financing for a Drug Manufacturers company?
A good Cash Flow for Lease Financing depends on the Drug Manufacturers industry context. However, Cash Flow for Lease Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Lease Financing mean?
A high Cash Flow for Lease Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing. View historical data on Labiana Health and its competitors. Labiana Health's current Cash Flow for Lease Financing is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labiana Health stock overvalued right now?
Based on GuruFocus' analysis, Labiana Health (XMAD:LAB) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.60, compared to a current price of €6.35 — trading 76.4% above its estimated fair value. The current Cash Flow for Lease Financing is €0.00 Mil. Labiana Health's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Lease Financing calculated?
Cash Flow for Lease Financing is calculated from a company's financial statements. For Labiana Health (XMAD:LAB), the current Cash Flow for Lease Financing is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labiana Health (XMAD:LAB) Overvalued in 2026?
Based on GuruFocus' analysis, Labiana Health stock appears to be overvalued.
The current stock price of €6.35 is trading 76.4% above its estimated GF Value™ of €3.60.
GuruFocus considers Labiana Health to be Significantly Overvalued.
Key valuation signals for XMAD:LAB:
Cash Flow for Lease Financing: €0.00 Mil
GF Value™: €3.60 vs. price of €6.35 (76.4% above fair value)
No single metric tells the full story. See the XMAD:LAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include a GMP manufacturer for EU animal and human health industries, a manufacturer specializing in sterile and lyophilized dosage forms, and a source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol. The company operates in two segment Animal Health and Human Health.
56GF Score
Get the complete analysis for XMAD:LAB
Cash Flow for Lease Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:LAB has been successfully added to your 
